ENGN Stock Analysis: Buy, Sell, or Hold?
ENGN - enGene Holdings Inc. Common Stock
$1.72
-7.13 (-80.56%)
▼
5d:
-76.34%
30d:
-76.47%
90d:
-80.59%
WAIT
LOW Confidence
Analysis Updated: May 7, 2026 12:00 AM ET
Earnings: Jun 11, 2026
Get Alerted When ENGN Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: ENGN is down 76.3% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: ENGN is down 76.3% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: ENGN is currently trading at $1.72, which is considered oversold relative to its 30-day fair value range of $6.08 to $8.58.
Technical Outlook: Technically, ENGN is in a downtrend. The price is currently testing key support at $1.74. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 80.6% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $23.27 (+1253.1%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, ENGN is in a downtrend. The price is currently testing key support at $1.74. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 80.6% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $23.27 (+1253.1%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$6.08 -
$8.58
Company Quality Score
41/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
77.4%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-80.6%)
- BULLISH: Trading 1253.1% below Wall St target ($23.27)
- WARNING: Recommendation downgraded due to -76.3% 5-day decline - wait for stabilization
Trading Range Analysis
30-Day Trading Range
$6.08 -
$8.58
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$1.74
Resistance Level
$9.00
Current Trend
Downtrend
Technical data as of
May 7, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-0.91
Wall Street Target
$23.27
(+1253.1%)
Share & Embed Analysis
Last updated: May 08, 2026 7:13 AM ET
Data refreshes hourly during market hours. Next update: 8:13 AM
Data refreshes hourly during market hours. Next update: 8:13 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ENGN showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$53 | 69 BUY |
|
VRTX
Vertex Pharmaceuticals I… |
BUY
34 analysts |
$548 | 61 BUY |
|
LEGN
Legend Biotech Corp |
STRONG BUY
22 analysts |
$57 | 55 HOLD |
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$79 | 59 HOLD |
|
REGN
Regeneron Pharmaceutical… |
STRONG BUY
25 analysts |
$875 | 49 HOLD |
